Clinical trialPhase 3
REMBRANDT
NCT06305559
Randomized double-blind placebo-controlled; primary endpoint percent change in total noncalcified coronary plaque volume by CCTA at 18 months.
No news refers to this card yet.
Scales
Identifiers
- NCT
- NCT06305559
Original sources
Details
- Phase
- Phase 3
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.